Jw Asset Management, LLC Adverum Biotechnologies, Inc. Transaction History

Jw Asset Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2018 May 11, 2018	SELL	$3.65 - $7.95 $652,087 - $1.42 Million	-178,654 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$2.45 - $3.65 $437,702 - $652,087	178,654	178,654 $652,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Jw Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Jw Asset Management, LLC with notifications on news.